TED Ted Baker Plc

RNS Number:1621Z
Tepnel Life Sciences PLC
02 March 2006



              Tepnel Life Sciences plc ('Tepnel' or 'the Company')



       Tepnel completes acquisition of GenXTrakTM DNA extraction business 
                             from Whatman plc


Manchester, UK, 2 March 2006 - The Board of Tepnel Life Sciences PLC (AIM: TED)
announced today the completed acquisition of the GenXTrak DNA extraction
business from UK-based Whatman plc (LSE:WHM.L) for an undisclosed sum. The
Cambridge-based GenXTrakTM business will now operate within Tepnel's service
division, offering rapid and reliable extraction, purification, quantification
and normalisation of clinical DNA samples. The acquisition expands Tepnel's
access to the pharmacogenomics testing market and positions the Company as one
of Europe's largest providers of DNA extraction services.

Commenting on the acquisition, Ben Matzilevich CEO, said: "The acquisition of
GenXTrak fits neatly into Tepnel's Research Products & Services division
creating additional capacity for our existing nucleic acid purification
business.  This business will provide access to European based customers and
expand our menu of capabilities allowing us to handle a variety of sample types.
An important component of Tepnel's strategic plan is to provide expanded
capabilities in both genetic and protein analysis.  In order to compete in these
markets Tepnel must be able to provide low cost, high throughput services while
meeting pharmaceutical standards.  We plan to automate the Whatman facility to
improve our competitive position.  Once implemented in Cambridge we plan to
expand these capabilities into our Edinburgh, Scotland and Stamford, USA
facilities."




Enquiries:


For Further Information:


Tepnel Life Sciences plc
Ben Matzilevich, CEO
0161 946 2200


Seymour Pierce
Mark Percy, Corporate Finance
0207 107 8000


De Facto Communications
Richard Anderson
020 7861 3838



Notes to Editors

About Tepnel Life Sciences plc

Tepnel is a UK-based international life sciences company focused on molecular
diagnostics and research products and services including DNA purification kits
and reagents, scientific services for nucleic acid purification, drug analysis,
genotyping and genetically modified foods. Tepnel was founded in 1992 to exploit
DNA technology generated at UMIST (University of Manchester Institute of Science
and Technology) and is quoted on the AIM segment of the London Stock Exchange
(AIM: TED). More information on Tepnel can be found at www.tepnel.com.



About GenXTrakTM

Located in Cambridge, the GenXTrak business combines highly effective,
proprietary methods for DNA processing with extensive in-house expertise to
purify and analyse DNA samples with great efficiency. The highly flexible
service is ISO9001 compliant  with a fully secured sample tracking system
(TRACKBASE) that uses barcode technology to guarantee sample integrity to ensure
the best possible results.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

ACQUAOBRNBRORAR

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024